Moderna Inc (MRNA)
$122.50
0.00 (0.00%)
MRNA Stock Quote Delayed 30 Minutes
Moderna Has Huge Growth Potential As Its Covid-19 Trials Wrap Up
Phase 3 trials for Moderna's coronavirus vaccine candidate could mean $37 billion in revenue for MRNA stock if mRNA-1273 wins approval.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
46.92B
PE Ratio
-7.82
EPS
-15.66
Volume (Avg. Vol.)
518
Day's Range
-
52-Week Range
$62.55 - $170.47
Dividend & Yield
N/A (N/A)
MRNA Stock Predictions, Articles, and Moderna Inc News
Aggressive Investors Have No Excuse for Not Owning Moderna
Canada just ordered 20 million doses of Moderna’s Covid-19 vaccine. That’s excellent news for anyone who owns MRNA stock, Canadians included.
Why Moderna May Be Ready to Deliver an October Surprise
MRNA stock is up 25% since early September on renewed hope the company gets its Covid-19 vaccine through clinical trials by November.
Moderna Stock Looks Like a Winner as the Covid-19 Vaccine Race Loosens
Moderna looks like it has a winner with its Covid-19 vaccine. MRNA stock could make $35 billion if it delivers 1 billion doses, making its $26 billion market cap look cheap.
Buy JetBlue Stock at These Levels and Sock It Away for the Recovery
While airlines are still plenty of volatility, I’d use the weakness to pick up "blood in the street" opportunities like JBLU stock.
Here’s Why Moderna Shares May Blast Higher Over the Next Few Weeks
Moderna’s R&D day was a non-event, while upcoming clinical data posts may re-ignite MRNA stock buying.
MRNA Stock: Moderna Rallies Thursday on Vaccine Timeline News
MRNA stock is rallying Thursday on news Moderna will wrap up its late-stage trials by the end of the year. Here's why it matters.
With Its Vaccine Trail, Moderna Addresses Racial Disparity Head On
With the race to find an effective vaccine tightening, MRNA stock just might have the inside lane due to lingering question marks about competing vaccine types. If so, Moderna can also do much good in addressing racial conflict in America.
After Vaccine Deal, Buy The Dip With Moderna Stock
Those who bought MRNA stock may be cashing out. But with risk/return still in your favor, taking a small position may be worthwhile.
4 Robinhood Stocks You Should Check Out, Too
Robinhood stocks that have a strong growth outlook and have presence in sectors that are in the limelight. These stocks are potential outperformers.
Believe It or Not, There’s Still Time to Buy Into Moderna Stock and Profit
With plenty of support from the Trump Administration, a bullish analyst, and nearing Phase 3 trial data, MRNA stock could explode higher.
Government Money Should Set Moderna Stock Back on the Path to Growth
Yes, Moderna is advanced, relative to many rivals, in its efforts to bring a Covid-19 vaccine to market. However, the combination of the gravity of this situation – industries, jobs and most importantly, human lives, hang in the balance – and the timeline of getting a treatment to market make for a situation where upside in MRNA stock is unlikely to be linear.
This Company is the Landlord of Life Sciences
Alexandria Real Estate Equities is the largest landlord in the US for laboratories and related offices.
As a Vaccine Looks More Likely, Moderna Stock Still Is a Good Bet
Pharmaceutical company Moderna is at the forefront of the global race to develop a vaccine against Covid-19. We could know as early as October whether Moderna's vaccine will be given the green light from regulators, and the company is already scaling up production to meet demand. Investors would be smart to buy MRNA shares now and ride them higher in the coming months.
4 Top Stock Trades for Thursday: DIS, SQ, ROKU, MRNA
A Roku earnings preview, along with Disney, Square and Moderna were our top stock trades from Wednesday. That said, let's look at the charts.
7 Growth Stocks to Ride for the Rest of 2020
Investors can count on these growth stocks to deliver consistent, positive returns for the remainder of this year and beyond.
